Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023)

Mirum Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $29000.0 for Q4 2023.

• On a quarterly basis, Amortizatization of Intangibles fell 97.15% year-over-year to $29000.0 in Q4 2023; TTM through Dec 2023 was $1.7 million, a 1.29% increase from a year earlier, with the FY2023 full-year figure at $1.7 million, up 1.29% from the prior year.
• Amortizatization of Intangibles retreated to $29000.0 in Q4 2023 per MIRM's latest filing, from $234000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $1.0 million in Q4 2022 and bottomed at -$45000.0 in Q2 2020.
• The 5-year median for Amortizatization of Intangibles is $58000.0 (2021), against an average of $208578.9.
• Across the five-year window, Amortizatization of Intangibles sank 228.57% in 2020 and surged 1742.22% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $127000.0 in 2019, then declined by 18.11% to $104000.0 in 2020, then tumbled by 45.19% to $57000.0 in 2021, then jumped by 1684.21% to $1.0 million in 2022, then plunged by 97.15% to $29000.0 in 2023.
• Per Business Quant, the three latest MIRM Amortizatization of Intangibles figures stand at $29000.0 (Q4 2023), $234000.0 (Q3 2023), and $633000.0 (Q2 2023).